auto_awesome_motion View all 2 versions
organization

AbbVie

AbbVie Inc.
Country: United States
21 Projects, page 1 of 5
  • Project . 2018 - 2020
    Open Access mandate for Publications and Research data
    Funder: EC Project Code: 807010
    Overall Budget: 2,140,980 EURFunder Contribution: 1,168,750 EUR
    Partners: CSL BEHRING GMBH, MHRA, AEMPS, International Health, UMC, PFIZER, Lareb, DANISH MEDICINES AGENCY, HALMED, AbbVie...

    This proposal seeks to build on the mobile application (app) functionality delivered through the original WEB-RADR project to expand access to the platform and the reach of the information contained within it. It will achieve this by making the functionality available through application programming interfaces (APIs), meaning that third party organisations will be able to embed WEB-RADR platform functionality into their own systems, applications and websites. An important component to this will be a terminology/classification mapping activity involving the three core healthcare terminology owners; MedDRA MSSO, SNOMED International and WHO. The mapping will facilitate communication between regulatory and healthcare databases by establishing mapping protocols and delivering an initial mapping between a subset of key pharmacovigilance terms. The project has established use cases and adopters for the proposed functionality through the networks established through the original WEB-RADR delivery, and has a diverse range of partners keen to utilise different aspects of the proposed solutions including regulatory authorities, health charities and system providers.

  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 806995
    Overall Budget: 604,042 EURFunder Contribution: 365,242 EUR
    Partners: GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD., Bayer AG, EATG, EFGCP, PFIZER, UCB Pharma (Belgium), NOVARTIS, Novo Nordisk, AbbVie, IPPOSI...

    The European Patients' Academy on Therapeutic Innovation (EUPATI) IMI project resulted in a number of key outputs for the field of patient engagement. The core activities continue running until 2019 under a PPP consortium under an EPF programme focusing on the Patient Expert Training Course, the multilingual public Toolbox, and the EUPATI National Platforms Network. It is imperative that these pillars that support the patient engagement landscape exist in the medium- and long-term to address the growing field of patient engagement. Further investment is needed to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for these to work, building on those already established under IMI-EUPATI.

  • Funder: EC Project Code: 115188
    Partners: EPFL, UH, Roche (Switzerland), ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH, Weizmann Institute of Science, AstraZeneca (Sweden), UT, STICHTING RADBOUD UNIVERSITEIT, BII GMBH, Instituto de Biologia Experimental Tecnológica...
  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 945345
    Overall Budget: 21,978,900 EURFunder Contribution: 10,476,700 EUR
    Partners: JDRF, EUROPEAN PATIENTS FORUM, The Hyve, TPIZ, Roche (Switzerland), TEAM - IT RESEARCH SL, ICS, NOVARTIS, Eli Lilly and Company Limited, STICHTING INTEGRAAL KANKERCENTRUM NEDERLAND...

    Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspective. We are currently not using all the information we could gain fromPatients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspective. We are currently not using all the information we could gain from Patient-Reported Outcomes (PROs) to accurately measure value from the patient perspective. This is due to the lack of standardisation, interoperability and implementation of PRO measurement schemes. We urgently need a European scale network of outcomes data collection, analysis and evidence sharing to inform clinical practice and healthcare decisions. To tackle these issues, this public-private consortium brings together scientists, clinicians and professionals to design and set up independent, patient-centred, Health Outcomes Observatories (H2Os). With input from patients, providers and health care decision makers (health ministries, health insurers, regional health authorities, public health agencies, medicines regulators, health technology assessment agencies), these Observatories will collect data and provide information not only for individual clinical care, but also for evaluation of new technologies and for healthcare decision making. We will establish ethically and legally sound national, or regional, H2Os and run these initially in four countries for three diseases. Based on a hybrid model of federated and centralised data collection, management and analysis, these Observatories will operate under a governance model that will guarantee that data are protected under jurisdictional data protection law. H2Os will be connected to a pan-European umbrella H2O to facilitate interoperability, guide reproducibility in other countries, and promote the benefit of measuring and using patient-centred outcomes at regional, national, European and global levels.

  • Funder: EC Project Code: 115770
    Partners: University of Surrey, UMC, LUMC, Newcastle University, FAU, Diakon, University of Leeds, IRIS, GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD., Universitätsklinikum Erlangen...